0001140361-17-022037.txt : 20170523
0001140361-17-022037.hdr.sgml : 20170523
20170523180352
ACCESSION NUMBER: 0001140361-17-022037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170519
FILED AS OF DATE: 20170523
DATE AS OF CHANGE: 20170523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Kenneth W.
CENTRAL INDEX KEY: 0001530777
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 17864961
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
4
1
doc1.xml
FORM 4
X0306
4
2017-05-19
0
0000722723
HANGER, INC.
HGR
0001530777
Wilson Kenneth W.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Pres./COO Southern Prosthetic*
Common Stock
52632
D
Stock Options (right to buy)
12.77
2017-05-19
4
A
0
54834
0
A
2027-05-19
Common Stock
54834
54834
D
Performance Share Units
2017-05-19
4
A
0
21934
0
A
2020-05-19
Common Stock
21934
21934
D
Includes (i) unvested restricted shares which total 11,000 shares of stock from an initial grant of 11,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 10,155 shares of stock from an initial grant of 11,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 5,320 shares of stock from an initial grant of 6,359 shares of restricted stock made on March 6, 2015; (v) unvested restricted shares and fully vested shares totaling 3,063 shares of stock from an initial grant of 3,661 shares of restricted stock made on March 7, 2014; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 5,839 shares of stock from an initial grant of 8,075 shares of restricted stock and performance shares made on March 11, 2013; (vii) fully vested shares totaling 6,833 shares of stock from an initial grant of 13,800 shares of restricted stock and performance shares made on March 7, 2012 and (viii) fully vested shares totaling 5,422 shares of stock from an initial grant of 15,000 shares of restricted stock made on September 19, 2011. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
* President and Chief Operating Officer of Southern Prosthetic Supply, Inc.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Kenneth W. Wilson
2017-05-23